A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas
- PMID: 23082819
- PMCID: PMC3488514
- DOI: 10.1186/1746-1596-7-145
A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas
Abstract
Background: Breast carcinomas can be classified into five subtypes based on gene expression profiling or immunohistochemical characteristics. Among these subtypes, basal-like breast carcinomas (BLBCs) are one of the most studied group, due to their poor prognosis. The aim of this study was to investigate the prevalance, morphological and immunohistochemical features of BLBCs, in Turkish population.
Methods: Five hundred invasive breast carcinomas were reviewed for several morphological features and immunostained for oestrogen and progesterone receptors, c-ERB-B2, cytokeratin5/6, cytokeratin14, vimentin and epidermal growth factor receptor (EGFR). Basal-like breast carcinoma was defined as a triple negative tumor with cytokeratin5/6 and/or EGFR positive.
Results: The prevalance of BLBC was 9.6%. All medullary carcinomas and 55.6% of metaplastic carcinomas showed basal-like immunophenotype. Patients with BLBC were younger (p=0.04) and had higher-grade tumors (p<0.0001). Morphologic features associated with BLBC included increased mitosis, nuclear pleomorphism, presence of geographic and/or central necrosis, pushing margin of invasion and stromal lymphocytic response (p<0.0001). Presence of prominent nucleoli and vesicular nuclear chromatin were the cytological features correlated with basal-like phenotype (p<0.0001). On multivariate analyses, BLBCs were associated with high mitotic number (p<0.0001), the presence of vesicular chromatin (p=0.004), high tubular grade (p=0.011), lymphocytic response (p=0.031) and the absence of carcinoma insitu (p=0.039). Vimentin was positive in 53.2% of BLBCs, while cytokeratin14 was less frequently expressed (27.7%).
Conclusions: BLBCs have some distinctive, but not pathognomonical, morphological features. Paying attention to these features and adding cytokeratin14 and vimentin to the immunohistochemical panel can help the definitive diagnosis of BLBCs.
Virtual slide: Http://www.diagnosticpathology.diagnomx.eu/vs/5962175467857400.
Figures


Similar articles
-
Metaplastic breast carcinomas and their relationship with basal-like phenotype.Turk Patoloji Derg. 2012;28(2):134-41. doi: 10.5146/tjpath.2012.01112. Turk Patoloji Derg. 2012. PMID: 22627631
-
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.Mod Pathol. 2006 Feb;19(2):264-71. doi: 10.1038/modpathol.3800528. Mod Pathol. 2006. PMID: 16341146
-
P-cadherin and vimentin are useful basal markers in breast cancers.Hum Pathol. 2013 Dec;44(12):2782-91. doi: 10.1016/j.humpath.2013.07.029. Epub 2013 Oct 16. Hum Pathol. 2013. PMID: 24139214
-
Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature.Mod Pathol. 2012 Apr;25(4):567-75. doi: 10.1038/modpathol.2011.190. Epub 2011 Dec 9. Mod Pathol. 2012. PMID: 22157932 Review.
-
Morphological and pathological features of basal-like breast cancer.Transl Cancer Res. 2019 Oct;8(Suppl 5):S503-S509. doi: 10.21037/tcr.2019.06.50. Transl Cancer Res. 2019. PMID: 35117128 Free PMC article. Review.
Cited by
-
Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2337-49. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24966944 Free PMC article.
-
The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.PLoS One. 2015 Mar 3;10(3):e0114820. doi: 10.1371/journal.pone.0114820. eCollection 2015. PLoS One. 2015. PMID: 25734578 Free PMC article.
-
Malignant adenomyoepithelioma combined with adenoid cystic carcinoma of the breast: a case report and literature review.Diagn Pathol. 2014 Jul 23;9:148. doi: 10.1186/1746-1596-9-148. Diagn Pathol. 2014. PMID: 25056281 Free PMC article. Review.
-
Expression of glucosylceramide synthase in invasive ductal breast cancer may be correlated with high estrogen receptor status and low HER-2 status.Diagn Pathol. 2014 Jan 23;9:22. doi: 10.1186/1746-1596-9-22. Diagn Pathol. 2014. PMID: 24456584 Free PMC article.
-
Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis.Hum Pathol. 2013 Dec;44(12):2743-50. doi: 10.1016/j.humpath.2013.07.021. Hum Pathol. 2013. PMID: 24262018 Free PMC article.
References
-
- World Health Organization Classification of Tumours. Invasive breast carcinoma. In: Tavassoli FA, Devilee P, editor. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003. pp. 13–59.
-
- Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736–1747. doi: 10.1093/annonc/mdr304. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous